The most common thresholds used for both HE4 and CA125 are those used for ovarian cancer detection [54,55]; however, the clinical and molecular profile of endometrial cancer differs to that of ovarian cancer, and so these thresholds are unlikely to be clinically useful. This evidence concerns the gene WFDC2 and ovarian carcinoma.